Table 3

Clinical characteristics of patients with type 2 diabetes analyzed in the IDMPS wave 5 by region and country

Country/regionCurrent smoker (%)Mean (SD) diabetes duration (years)Screened for diabetes-related complications (%)*With microvascular complications (%)*With macrovascular complications (%)*With HbA1c<7% (%)Familial history of T2DM (%)
Eurasia (n=1834)9.88.7 (7.1)9987472137.9
Georgia (n=152)13.210.7 (8.6)999174442.8
Kazakhstan (n=413)11.18.1 (7.3)10089402127.4
Russia (n=540)9.39.5 (7.4)9981422940.9
Ukraine (n=353)8.59.2 (6.3)9789531541.8
Uzbekistan (n=376)8.86.8 (5.7)10089472339.6
Africa (n=2220)†8.18.6 (7.2)9341143152.3
Algeria (n=514)4.58.8 (7.1)9741154451.3
Cameroon (n=524)2.76.6 (6.9)904862844.5
Egypt (n=371)17.89.4 (7.7)9347202258.2
Morocco (n=498)5.09.0 (7.0)9130152753.7
Tunisia (n=313)16.910.0 (6.7)9839152358.5
Middle East (n=2065)22.98.3 (7.2)9635153759.5
Jordan (n=296)28.76.6 (5.9)9330153455.4
KSA (n=199)18.610.2 (8.2)9448193163.3
Lebanon (n=1059)28.08.1 (7.2)9535173660.4
UAE (n=511)10.69.1 (7.0)9930104258.3
South Asia (n=1195)8.89.0 (6.7)9141142543.2
India (n=994)7.79.1 (6.5)9137112643.0
Pakistan (n=201)14.48.2 (7.2)9262272244.6
Turkey (n=842)14.58.7 (6.8)9442202855.5
  • *Missing data are considered for percentage calculations.

  • †Owing to the small sample size (N=50), Senegal was not included in Africa results in this table.

  • HbA1c, glycated hemoglobin; KSA, Kingdom of Saudi Arabia; T2DM, type 2 diabetes mellitus; UAE,United Arab Emirates.